Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
In the Q2W GZR18 dose groups, participants experienced ... Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback